Editorial Perspectives On Data Management & Analysis

  1. Can Smarter Study Design Relieve The Recruitment Challenge? 9/18/2021

    Recruitment has always been a challenge for companies conducting clinical trials. Sponsor companies seeking new ways to engage and recruit patients have seen varied success. But could that challenge be mitigated or eliminated with smarter study design?

  2. How Otsuka Uses Decentralized Trials & Real-World Evidence 8/3/2021

    Prior to joining Otsuka in 2019, Christoph Koenen spent two years with GSK, 10 years with Novo Nordisk, and eight years with BMS. I recently spoke to him about some of the key lessons he’s learned over the years and how Otsuka is applying new clinical trial strategies and technologies, especially for the treatment of patients in mental health trials.

  3. Is AI Improving Outcomes In Clinical Trials? 1/21/2021

    In October 2020, I hosted a webinar on the topic of AI and how it will improve outcomes in clinical trials. This article highlights some of the comments from that discussion.

  4. A New Technology Takes Alkermes Into Oncology 10/6/2020

    Moving into a new therapeutic area is a difficult proposition for most companies. That is not news to Blair Jackson. Jackson, the SVP of corporate planning at Alkermes, has been with the company for more than 21 years and knows the challenges of moving into research on new diseases.

  5. Pharma's Investment In RWE Is Beginning To Pay Off 7/7/2020

    For years the life sciences industry has heard about the benefits of investing in real-world evidence (RWE) and real-world data (RWD). According to a recent report from Deloitte, that investment may finally be paying off for companies that climbed onboard and have been building those capabilities.

  6. Teva Develops First FDA-Approved Digitally-Integrated Inhaler 1/8/2020

    Two challenges have plagued asthma sufferers and researchers for year. The first is patients not adhering to their maintenance medication. The other is patients not using proper inhaler technique. A new digitally-integrated inhaler from Teva hopes to eliminate both problems.

  7. BMS-Pfizer Alliance Evaluates AFib Screening And Stroke Connection 12/10/2019

    In November 2019, the BMS-Pfizer Alliance announced the initiation of a new randomized, controlled study called GUARD-AF. The trial will evaluate whether atrial fibrillation (AFib) screening can ultimately impact the rate of stroke, compared to standard medical care in older individuals in a real-world setting.

  8. Study Reveals Nearly $215 Billion Economic Burden Of Nocturia 12/3/2019

    Dr. Jay Jhaveri, lead investigator for Ferring Pharmaceuticals, knew that nocturia was a burden to many patients and to the U.S. economy. Unfortunately, no HEOR existed for nocturia. For that reason, Ferring decided to produce its own. To get the real-world information it needed on the prevalence of the condition, the company turned to the National Health and Nutrition Examination Survey (NHANES).

  9. Can Activity Trackers Create Better Clinical Trials? 9/6/2018

    I recently reported on data collected from Fitbit activity trackers. Fitbit has compiled 150 billion hours of data on the resting heart rate (RHR) of tens of millions of people around the world who used a Fitbit. Can this type of data help researchers, especially cardiologists, conduct better clinical trials on heart patients in the future?

  10. Three Ways To Improve Quality In Clinical Trial Processes 10/24/2017

    Timeliness, cost, and quality are all critical factors that must come together to ensure an efficient and successful clinical trial. Unfortunately, the complexity of trials, combined with coordination challenges, force sponsors to have to identify the opportunities needed to improve trials. But how do you know what efforts will produce the best results?